Presentation is loading. Please wait.

Presentation is loading. Please wait.

Crizotinib administered via nasogastric and percutaneous endoscopic gastrostomy tubes for the successful treatment of ALK-rearranged lung cancer in a.

Published byArron Stevens Modified over 6 years ago

Similar presentations

Presentation on theme: "Crizotinib administered via nasogastric and percutaneous endoscopic gastrostomy tubes for the successful treatment of ALK-rearranged lung cancer in a."— Presentation transcript:

1 Crizotinib administered via nasogastric and percutaneous endoscopic gastrostomy tubes for the successful treatment of ALK-rearranged lung cancer in a patient with poor performance status  Koji Tamai, Kazuma Nagata, Kyoko Otsuka, Atsushi Nakagawa, Ryo Tachikawa, Kojiro Otsuka, Nobuyuki Katakami, Keisuke Tomii  Respiratory Investigation  Volume 51, Issue 1, Pages (March 2013) DOI: /j.resinv Copyright © 2012 The Japanese Respiratory Society Terms and Conditions

2 Fig. 1 (A) A chest X-ray showing the primary lung adenocarcinoma lesion. (B) A chest X-ray obtained on the 24th day after the initiation of crizotinib treatment. Respiratory Investigation  , 46-48DOI: ( /j.resinv ) Copyright © 2012 The Japanese Respiratory Society Terms and Conditions

3 Fig. 2 (A) Chest computed tomography (CT) showing enlarged mediastinal lymph nodes, indicating metastasis and the primary lesion. (B) Chest CT obtained on the 31st day after the initiation of crizotinib treatment. Respiratory Investigation  , 46-48DOI: ( /j.resinv ) Copyright © 2012 The Japanese Respiratory Society Terms and Conditions

Download ppt "Crizotinib administered via nasogastric and percutaneous endoscopic gastrostomy tubes for the successful treatment of ALK-rearranged lung cancer in a."

Similar presentations

Choroidal Metastases Responsive to Crizotinib Therapy in a Lung Adenocarcinoma Patient with ALK 2p23 Fusion Identified by ALK Immunohistochemistry Yan.

Choroidal Metastases Responsive to Crizotinib Therapy in a Lung Adenocarcinoma Patient with ALK 2p23 Fusion Identified by ALK Immunohistochemistry Yan.
A long-term survivor of non-small-cell lung cancer harboring concomitant EGFR mutation and ALK translocation  Fumio Imamura, Takako Inoue, Madoka Kimura,

A long-term survivor of non-small-cell lung cancer harboring concomitant EGFR mutation and ALK translocation  Fumio Imamura, Takako Inoue, Madoka Kimura,
Ahsan R. Akram, John H. Reid, William Wallace, Simon W

Ahsan R. Akram, John H. Reid, William Wallace, Simon W
Kazuma Nagata, MD, Reiko Kaji, MD, Keisuke Tomii, MD 

Kazuma Nagata, MD, Reiko Kaji, MD, Keisuke Tomii, MD 
Steroid-related emphysematous cystitis in an EGFR-mutant patient with lung adenocarcinoma while on gefitinib treatment  Diego Marquez-Medina, Sanjay Popat 

Steroid-related emphysematous cystitis in an EGFR-mutant patient with lung adenocarcinoma while on gefitinib treatment  Diego Marquez-Medina, Sanjay Popat 
Hiromasa Nakayasu, Toshihiro Shirai, Yuko Tanaka, Mika Saigusa 

Hiromasa Nakayasu, Toshihiro Shirai, Yuko Tanaka, Mika Saigusa 
Lung cancer in patients diagnosed with silicosis should be investigated  Adil Can Güngen, Yusuf Aydemir, Hikmet Çoban, Hasan Düzenli, Canantan Tasdemir 

Lung cancer in patients diagnosed with silicosis should be investigated  Adil Can Güngen, Yusuf Aydemir, Hikmet Çoban, Hasan Düzenli, Canantan Tasdemir 
Esophageal adenocarcinoma five years after laparoscopic sleeve gastrectomy. A case report  Fernando Gabriel Wright, Agustin Duro, Juan Rodolfo Medici,

Esophageal adenocarcinoma five years after laparoscopic sleeve gastrectomy. A case report  Fernando Gabriel Wright, Agustin Duro, Juan Rodolfo Medici,
Droplet Digital PCR for Absolute Quantification of EML4-ALK Gene Rearrangement in Lung Adenocarcinoma  Qiushi Wang, Xin Yang, Yong He, Qiang Ma, Li Lin,

Droplet Digital PCR for Absolute Quantification of EML4-ALK Gene Rearrangement in Lung Adenocarcinoma  Qiushi Wang, Xin Yang, Yong He, Qiang Ma, Li Lin,
Secondary Mutations at I1171 in the ALK Gene Confer Resistance to Both Crizotinib and Alectinib  Gouji Toyokawa, MD, PhD, Fumihiko Hirai, MD, PhD, Eiko.

Secondary Mutations at I1171 in the ALK Gene Confer Resistance to Both Crizotinib and Alectinib  Gouji Toyokawa, MD, PhD, Fumihiko Hirai, MD, PhD, Eiko.
Peritonitis Secondary to the Migration of a Trans-Hepatically–Placed Percutaneous Endoscopic Gastrostomy Tube: A Case Report  David T. Burke, MD, MA,

Peritonitis Secondary to the Migration of a Trans-Hepatically–Placed Percutaneous Endoscopic Gastrostomy Tube: A Case Report  David T. Burke, MD, MA,
Mediastinal lymph node staging of non-small-cell lung cancer: A prospective comparison of computed tomography and positron emission tomography  Walter.

Mediastinal lymph node staging of non-small-cell lung cancer: A prospective comparison of computed tomography and positron emission tomography  Walter.
Abscopal Effect of Nivolumab in a Patient with Primary Lung Cancer

Abscopal Effect of Nivolumab in a Patient with Primary Lung Cancer
Hiren J. Mehta, MD, Tan-Lucien Mohammed, MD, Michael A. Jantz, MD 

Hiren J. Mehta, MD, Tan-Lucien Mohammed, MD, Michael A. Jantz, MD 
A Proposal for Definition of Minimally Invasive Adenocarcinoma of the Lung Regardless of Tumor Size  Shigeki Suzuki, MD, Hiroyuki Sakurai, MD, Kyohei.

A Proposal for Definition of Minimally Invasive Adenocarcinoma of the Lung Regardless of Tumor Size  Shigeki Suzuki, MD, Hiroyuki Sakurai, MD, Kyohei.
Primary pulmonary hepatoid adenocarcinoma: A case report

Primary pulmonary hepatoid adenocarcinoma: A case report
ALK FISH and IHC: You Cannot Have One without the Other

ALK FISH and IHC: You Cannot Have One without the Other
Palliative Neck Surgery in Metastatic Lung Cancer: A Case Report

Palliative Neck Surgery in Metastatic Lung Cancer: A Case Report
Oxygen-Exacerbated Bleomycin Pulmonary Toxicity

Oxygen-Exacerbated Bleomycin Pulmonary Toxicity
Afatinib-Induced Severe Interstitial Lung Disease Successfully Treated with High-Dose Corticosteroid Therapy: A Case Report  Kazutaka Fujita, MD, Yuko.

Afatinib-Induced Severe Interstitial Lung Disease Successfully Treated with High-Dose Corticosteroid Therapy: A Case Report  Kazutaka Fujita, MD, Yuko.

Similar presentations

Ads by Google